Christopher G Parker

Scripps Florida

$3,542,524

Attributed

$4,211,282

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2021–25

$2M$1.5M$1M$500K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,211,282 · 2

By mechanism

R01$4,211,282 · 2

Top collaborators

Others in their field

Other Emerging Leaders on “Metabolic”

Xinhua Li · Nano Terra, Inc.$29,991,620
Barbara Halina Braffett · George Washington University$22,016,904
Ionut Bebu · George Washington University$18,816,779
Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
Rainer Lohmann · University Of Rhode Island$14,400,221
Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023

Research focus

MetabolicCellsInfectionMass Spectrum AnalysisPathogenTherapeutic TargetImmuneImmunologyInnovationMacrophageMolecularMouse ModelProteinsProteomicsChemoproteomicsDendritic CellsBiochemicalImmune ResponseBiologyB-LymphocytesIn VivoIn Vivo ModelDisease ModelEnvironmental Risk Factor

Grant awards (7)

Chemoproteomic discovery and functional analysis microbiota bile acid-protein targets in host immunity$891,678

R01 · FY2025 · AI

Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation$696,479

R01 · FY2025 · AI · contact PI

Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation$685,123

R01 · FY2024 · AI · contact PI

Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation$685,123

R01 · FY2023 · AI · contact PI

Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation$685,123

R01 · FY2022 · AI · contact PI

Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation$395,321

R01 · FY2021 · AI · contact PI

Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation$172,435

R01 · FY2021 · AI · contact PI